Dexcom shares plunge on lower sales outlook
“I’m just kind of in shock,” an analyst said on the earnings call, asking for more detail on the forecast cut.
“I’m just kind of in shock,” an analyst said on the earnings call, asking for more detail on the forecast cut.
A spokesperson for Abbott said the recall “may impact less than 1% of Libre 3 users in the U.S.”
The European Medicines Agency’s Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment.
Encouraged by the potential of the weight-loss candidates acquired from Carmot Therapeutics, Roche will speed up the development of its obesity programs, seeking to differentiate itself in the market.
Bristol Myers Squibb on Friday reported strong second-quarter results, led by the blood thinner Eliquis and cancer therapy Opdivo, as it looks to cut $1.5 billion in costs by 2025.
La era de la inteligencia artificial (IA) ha llegado al marketing digital, transformando por completo la manera en que las empresas interactúan con sus audiencias. En este artículo, vamos a presentarte cómo la IA está revolucionando el marketing digital en Espa& …
En este artículo, vamos a presentarte un tema fundamental para el sector farmacéutico en España: el Sistema Personalizado de Dosificación (SPD). Este sistema está revolucionando la forma en que se dispensan los medicamentos, mejorando la adherencia al tratamiento y …
Despite their initial kicking and screaming, drugmakers seem confident the Inflation Reduction Act’s Medicare Drug Price Negotiation Program will not greatly impact their bottom lines.
La App Olimpobet ha crecido rápidamente hasta convertirse en un actor destacado en el mercado de apuestas online de Perú. Esta completa plataforma ofrece una interfaz de usuario fluida e intuitiva, lo que la hace accesible tanto para apostadores novatos como experimentados. L …
The company’s FcRn inhibitor Vyvgart grew 17% quarter-over-quarter, reigniting confidence it will hit its ambitious goals despite a string of clinical setbacks in recent months.